Cargando…
Urine myo-inositol as a novel prognostic biomarker for diabetic kidney disease: a targeted metabolomics study using nuclear magnetic resonance
BACKGROUND: As a leading cause of chronic kidney disease, clinical demand for noninvasive biomarkers of diabetic kidney disease (DKD) beyond proteinuria is increasing. Metabolomics is a popular method to identify mechanisms and biomarkers. We investigated urinary targeted metabolomics in DKD patient...
Autores principales: | Kwon, Soie, Hyeon, Jin Seong, Jung, Youngae, Li, Lilin, An, Jung Nam, Kim, Yong Chul, Yang, Seung Hee, Kim, Tammy, Kim, Dong Ki, Lim, Chun Soo, Hwang, Geum-Sook, Lee, Jung Pyo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Nephrology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10407640/ https://www.ncbi.nlm.nih.gov/pubmed/37551126 http://dx.doi.org/10.23876/j.krcp.22.152 |
Ejemplares similares
-
Urinary myo-inositol is associated with the clinical outcome in focal segmental glomerulosclerosis
por: An, Jung Nam, et al.
Publicado: (2019) -
Urinary Metabolomic Profiling in Streptozotocin-Induced Diabetic Mice after Treatment with Losartan
por: Hyeon, Jin Seong, et al.
Publicado: (2020) -
Inhibited inositol monophosphatase and decreased myo‐inositol concentration improve wasting in skeletal muscles
por: Lee, Ji‐Hyung, et al.
Publicado: (2020) -
Determination of Urinary Myo-/Chiro-Inositol Ratios from Korean Diabetes Patients
por: Jung, Tae-Sik, et al.
Publicado: (2005) -
Role of an unclassified Lachnospiraceae in the pathogenesis of type 2 diabetes: a longitudinal study of the urine microbiome and metabolites
por: Kim, Kangjin, et al.
Publicado: (2022)